Drug-based mobilisation of mesenchymal stem/stromal cells improves cardiac function post myocardial infarction
Saved in:
Main Authors: | Veneta B. Todorova (Author), Nicoleta Baxan (Author), Matthew Delahaye (Author), Sian E. Harding (Author), Sara M. Rankin (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Myocardial Infarction Reduces Respiration in Rat Cardiac Fibers, despite Adipose Tissue Mesenchymal Stromal Cell Transplant
by: Camila I. Irion, et al.
Published: (2020) -
An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism
by: Weizhang Xiao, et al.
Published: (2023) -
Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction
by: Yue Tao, et al.
Published: (2022) -
Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction
by: Yue Tao, et al.
Published: (2022) -
Wharton's Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View
by: Noelia Muñoz-Domínguez, et al.
Published: (2021)